hMAO-B-IN-8
Product Specifications
UNSPSC Description
hMAO-B-IN-8 (Compound 23) is a hMAO-B, eeAChE, COX-2 and 5-LOX inhibitor, with IC50 values of 0.037 μM, 0.071 μM, 14.3 μM and 0.59 μM, respectively. hMAO-B-IN-8 can be used for the research of Alzheimer's disease[1].
Target Antigen
Cholinesterase (ChE); COX; Lipoxygenase; Monoamine Oxidase
Type
Reference compound
Related Pathways
Immunology/Inflammation;Metabolic Enzyme/Protease;Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/hmao-b-in-8.html
Smiles
O=C(NC1=NC2=CC=C(O)C=C2S1)/C=C/C3=CC=C(C4=CC=CC=C4)C=C3
Molecular Weight
372.44
References & Citations
[1]Hussain F, et al. Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation. RSC Adv. 2024 Mar 28;14(15):10304-10321.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162523/hMAO-B-IN-8-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162523/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
